164 related articles for article (PubMed ID: 18976022)
1. Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread.
Posligua L; Malpica A; Liu J; Brown J; Deavers MT
Arch Pathol Lab Med; 2008 Nov; 132(11):1821-4. PubMed ID: 18976022
[TBL] [Abstract][Full Text] [Related]
2. Mixed large and small cell neuroendocrine carcinoma of the endometrium with serous carcinoma: A case report and literature review.
Hu R; Jiang J; Song G; Zhu C; Chen L; Wang C; Wang X
Medicine (Baltimore); 2019 Jul; 98(29):e16433. PubMed ID: 31335697
[TBL] [Abstract][Full Text] [Related]
3. Large cell neuroendocrine carcinoma of the endometrium: an extremely uncommon diagnosis, but worth the efforts.
Deodhar KK; Kerkar RA; Suryawanshi P; Menon H; Menon S
J Cancer Res Ther; 2011; 7(2):211-3. PubMed ID: 21768718
[TBL] [Abstract][Full Text] [Related]
4. Synchronous endometrioid carcinoma of the endometrium and small cell neuroendocrine carcinoma of the cervix: a rare combination.
Nakra T; Biswas R; Pandey R; Yadav R
BMJ Case Rep; 2018 Nov; 2018():. PubMed ID: 30413462
[TBL] [Abstract][Full Text] [Related]
5. Combined large-cell neuroendocrine carcinoma and endometrioid adenocarcinoma of the endometrium: A case report and survey of related literature.
Matsumoto H; Nasu K; Kai K; Nishida M; Narahara H; Nishida H
J Obstet Gynaecol Res; 2016 Feb; 42(2):206-10. PubMed ID: 26807962
[TBL] [Abstract][Full Text] [Related]
6. Collision Tumor of Endometrial Large Cell Neuroendocrine Carcinoma and Low-Grade Endometrial Stromal Sarcoma: A Case Report and Review of the Literature.
Rivera G; Niu S; Chen H; Fahim D; Peng Y
Int J Surg Pathol; 2020 Aug; 28(5):569-573. PubMed ID: 31992096
[TBL] [Abstract][Full Text] [Related]
7. Small Cell Neuroendocrine Carcinoma of the Endometrium with Difficulty Identifying the Original Site in the Uterus.
Iida T; Muramatsu T; Kajiwara H; Kato N; Itoh H; Narayama T; Machida H; Ikeda M; Shida M; Hirasawa T; Mikami M
Tokai J Exp Clin Med; 2020 Dec; 45(4):156-161. PubMed ID: 33300584
[TBL] [Abstract][Full Text] [Related]
8. Large cell neuroendocrine carcinoma of the endometrium: A case report and literature review.
Tu YA; Chen YL; Lin MC; Chen CA; Cheng WF
Taiwan J Obstet Gynecol; 2018 Feb; 57(1):144-149. PubMed ID: 29458887
[TBL] [Abstract][Full Text] [Related]
9. An unusual composite endometrial tumor combining papillary serous carcinoma and small cell carcinoma.
Shaco-Levy R; Manor E; Piura B; Ariel I
Am J Surg Pathol; 2004 Aug; 28(8):1103-6. PubMed ID: 15252320
[TBL] [Abstract][Full Text] [Related]
10. Expression of neuroendocrine markers in non-neuroendocrine endometrial carcinomas.
Moritz AW; Schlumbrecht MP; Nadji M; Pinto A
Pathology; 2019 Jun; 51(4):369-374. PubMed ID: 31040050
[TBL] [Abstract][Full Text] [Related]
11. Pure papillary serous tumors of the endometrium: a clinicopathological analysis of 61 cases from a single institution.
Benito V; Lubrano A; Arencibia O; Alvarez EE; León L; Medina N; Falcón JM; Falcón O
Int J Gynecol Cancer; 2009 Nov; 19(8):1364-9. PubMed ID: 20009891
[TBL] [Abstract][Full Text] [Related]
12. Pathological findings in early-stage endometrial cancer.
Zehavi S; Schneider D; Bukovsky I; Halperin R
Eur J Gynaecol Oncol; 2003; 24(1):18-20. PubMed ID: 12691310
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical comparison of uterine papillary serous and papillary endometrioid carcinoma: clues to pathogenesis.
Demopoulos RI; Mesia AF; Mittal K; Vamvakas E
Int J Gynecol Pathol; 1999 Jul; 18(3):233-7. PubMed ID: 12092593
[TBL] [Abstract][Full Text] [Related]
14. Large cell neuroendocrine carcinoma with sarcomatous changes of the endometrium: a case report with immunohistochemical studies and molecular genetic study of KIT and PDGFRA.
Terada T
Pathol Res Pract; 2010 Jun; 206(6):420-5. PubMed ID: 20189318
[TBL] [Abstract][Full Text] [Related]
15. CD10 expression in the neuroendocrine carcinoma component of endometrial mixed carcinoma: association with long survival.
Uehara K; Ikehara F; Tanabe Y; Nakazato I; Oshiro M; Inamine M; Kinjo T
Diagn Pathol; 2016 Feb; 11():16. PubMed ID: 26830028
[TBL] [Abstract][Full Text] [Related]
16. Pathological processes and pretreatment cytologic diagnosis of neuroendocrine carcinoma of the endometrium: addendum report of the Kansai Clinical Oncology Group/Intergroup study in Japan.
Matsumoto H; Nasu K; Shikama A; Shiozaki T; Futagami M; Kai K; Mori T; Yano M; Yamada T; Teramoto N
Med Mol Morphol; 2021 Sep; 54(3):237-244. PubMed ID: 33934220
[TBL] [Abstract][Full Text] [Related]
17. Markers of proliferative activity are predictors of patient outcome for low-grade endometrioid adenocarcinoma but not papillary serous carcinoma of endometrium.
Al Kushi A; Lim P; Aquino-Parsons C; Gilks CB
Mod Pathol; 2002 Apr; 15(4):365-71. PubMed ID: 11950909
[TBL] [Abstract][Full Text] [Related]
18. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
Bartosch C; Manuel Lopes J; Oliva E
Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
[TBL] [Abstract][Full Text] [Related]
19. Papillary carcinoma of the endometrium: morphometric predictors of survival.
Demopoulos RI; Genega E; Vamvakas E; Carlson E; Mittal K
Int J Gynecol Pathol; 1996 Apr; 15(2):110-8. PubMed ID: 8786199
[TBL] [Abstract][Full Text] [Related]
20. Uterine papillary serous carcinoma.
Moore KN; Fader AN
Clin Obstet Gynecol; 2011 Jun; 54(2):278-91. PubMed ID: 21508697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
